Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating
CA 2413022 A1 · Owner: Diversa Corporation · Inventors: Short, Jay M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An invention comprising cellular transformation directed evolution, and , screening methods for creating novel transgenic organisms having desirable properties. Thus in one aspect, this invention relates to a method of generating a transgenic organism, such as a microbe or a plant having a , plurality of traits that are differentially activatable. Also a method of , retooling genes and gene pathways by the introduction of regulatory sequences such as promoters, that are operable in an intended host thus conferring , operability to a novel gene pathway when it is introduced into an intended host. For example a novel man-made gene pathway generated based on , microbially-derived progenitor …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 14, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 14, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 14, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.